Placeholder

Brimonidine Tartrate

 

CAS No:
79570-19-7 Categories: , ,
  • # LGM Pharma is a Brimonidine Tartrate CAS# 79570-19-7 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, samples, sourcing, purity and more.
  • # Questions? Call our customer API support number 1-(800)-881-8210.
  • # LGM Pharma offers this active ingredient but not the finished dosage forms.
  • Inquire about this product >>

Product Details:

  • Product Name: Brimonidine Tartrate
  • CAS #: 79570-19-7
  • Mode of Action:

    Brimonidine is an alpha adrenergic receptor agonist (primarily alpha-2). It has a peak ocular hypotensive effect occurring at two hours post-dosing. Fluorophotometric studies in animals and humans suggest that Brimonidine has a dual mechanism of action by reducing aqueous humor production and increasing uveoscleral outflow. The topical gel reduces erythema through direct vasocontriction.

  • Pharmacodynamics:

    Brimonidine significantly lowers intraocular pressure with minimal effects on cardiovascular and pulmonary parameters. It lowers intraocular pressure by reducing aqueous humor production and increasing uveoscleral outflow.

  • Metabolism:

    Metabolized primarily by the liver.

  • Toxicity:

    Oral LD50 is 50 mg/kg in mice and 100 mg/kg in rats. Common adverse reactions of the topical gel formulation include erythema, flushing, skin burning sensation, and contact dermatitis.

  • IUPAC: 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
  • ATC: D11AX21 — Brimonidine, S01EA05 — Brimonidine
  • PubChem: 2435
  • DrugBank: DB00484 (APRD00034)
  • Formula: C11H10BrN5
  • Molecular Mass: 292.135
  • Synonyms: 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline, Brimonidina, Brimonidine, Brimonidinum, Bromoxidine
  • SMILES: BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12
  • AHFS Code: 52:40.04 — Alpha-adrenergic Agonists, 84:92.00 — Misc. Skin and Mucous Membrane Agents
  • InChl: InChI=1S/C11H10BrN5/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8/h1-4H,5-6H2,(H2,15,16,17)
  • Date Modified: 03-12-19
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
  • Premium quality GMP certified and fully accredited API manufacturing plants

 

  • Technical packages as well as access to filed DMF,
    ASMF or CEP (subject to availability)
  • Regulatory and technical assistance towards any
    submission type based on specific customer requirements
This website uses cookies. By using our site, you agree to our terms of service